{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T08:04:43Z","timestamp":1795161883257,"version":"4.10.3"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.prostaglandins.2019.106385","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:05:10Z","timestamp":1572897910000},"page":"106385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases"],"prefix":"10.1016","volume":"147","author":[{"given":"Jogen","family":"Atone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrc2015","article-title":"The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis","volume":"6","author":"Nebert","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/bbrc.2001.5167","article-title":"The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation","volume":"285","author":"Capdevila","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5548","key":"10.1016\/j.prostaglandins.2019.106385_bib0020","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.prostaglandins.2019.106385_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20070089","article-title":"Prostaglandins in the kidney: developments since Y2K","volume":"113","author":"Nasrallah","year":"2007","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.56.3.657","article-title":"Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor","volume":"56","author":"Sarau","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2019.106385_bib0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/11316780-000000000-00000","article-title":"NSAID use and the risk of Parkinson\u2019s disease: systematic review and meta-analysis of observational studies","volume":"26","author":"Samii","year":"2009","journal-title":"Drugs Aging"},{"issue":"19","key":"10.1016\/j.prostaglandins.2019.106385_bib0040","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-3-12","article-title":"Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia","volume":"3","author":"Jatana","year":"2006","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.07-9131.com","article-title":"5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer\u2019s disease","volume":"22","author":"Firuzi","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.06.014","article-title":"Protection of dopaminergic neurons by 5-lipoxygenase inhibitor","volume":"73","author":"Kang","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0065","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.HYP.34.6.1242","article-title":"Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells","volume":"34","author":"Fang","year":"1999","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0070","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids","volume":"51","author":"Morisseau","year":"2010","journal-title":"J. Lipid Res."},{"issue":"16","key":"10.1016\/j.prostaglandins.2019.106385_bib0075","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.45.120403.100045","article-title":"Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation","volume":"45","author":"Kroetz","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0085","article-title":"20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis","author":"Han","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(93)90805-R","article-title":"Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid","volume":"230","author":"Hu","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0100","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.RES.0000194321.60300.d6","article-title":"TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels","volume":"97","author":"Earley","year":"2005","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI116215","article-title":"Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids","volume":"91","author":"Satoh","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0110","doi-asserted-by":"crossref","first-page":"F155","DOI":"10.1152\/ajprenal.00231.2005","article-title":"Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP\/PKA pathway","volume":"291","author":"Carroll","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/jpet.108.145102","article-title":"Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation","volume":"328","author":"Behm","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.prostaglandins.2019.106385_bib0120","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI13241","article-title":"Regulated formation of eicosanoids","volume":"107","author":"Fitzpatrick","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"Suppl","key":"10.1016\/j.prostaglandins.2019.106385_bib0125","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","article-title":"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism","volume":"1851","author":"Spector","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/dmd.112.049429","article-title":"Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily","volume":"41","author":"Graves","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0003-9861(83)90628-8","article-title":"The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase","volume":"223","author":"Chacos","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0145","doi-asserted-by":"crossref","first-page":"H2306","DOI":"10.1152\/ajpheart.00448.2002","article-title":"Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide","volume":"283","author":"Fang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4-5","key":"10.1016\/j.prostaglandins.2019.106385_bib0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejps.2012.12.013","article-title":"Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models","volume":"48","author":"Liu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"Pt A","key":"10.1016\/j.prostaglandins.2019.106385_bib0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.prostaglandins.2015.06.005","article-title":"Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): resulting drug levels and modulation of oxylipin pattern","volume":"121","author":"Ostermann","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1194\/jlr.M031914","article-title":"Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo","volume":"54","author":"Kundu","year":"2013","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0165","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm0597-562","article-title":"Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase","volume":"3","author":"Moghaddam","year":"1997","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/abbi.2001.2434","article-title":"Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction","volume":"392","author":"Sisemore","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0175","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1194\/jlr.M002436","article-title":"A. Makriyannis. Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma","volume":"51","author":"Wood","year":"2010","journal-title":"J. Lipid Res."},{"issue":"5-6","key":"10.1016\/j.prostaglandins.2019.106385_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.plefa.2007.10.016","article-title":"The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition","volume":"77","author":"Brenna","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0185","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1194\/jlr.M047357","article-title":"Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway","volume":"55","author":"Fischer","year":"2014","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0190","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3945\/ajcn.110.006643","article-title":"Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century","volume":"93","author":"Blasbalg","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0006-2952(95)00167-X","article-title":"Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice","volume":"50","author":"Pinot","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/oby.2009.227","article-title":"Expression and regulation of soluble epoxide hydrolase in adipose tissue","volume":"18","author":"De Taeye","year":"2010","journal-title":"Obesity Silver Spring (Silver Spring)"},{"issue":"13","key":"10.1016\/j.prostaglandins.2019.106385_bib0205","doi-asserted-by":"crossref","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","article-title":"Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress","volume":"113","author":"Ren","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"25","key":"10.1016\/j.prostaglandins.2019.106385_bib0210","doi-asserted-by":"crossref","first-page":"E5815","DOI":"10.1073\/pnas.1802179115","article-title":"Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease","volume":"115","author":"Ren","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","article-title":"Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism","volume":"163","author":"Marowsky","year":"2009","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1369\/jhc.2008.950659","article-title":"Distribution and expression of soluble epoxide hydrolase in human brain","volume":"56","author":"Sura","year":"2008","journal-title":"J. Histochem. Cytochem."},{"issue":"61","key":"10.1016\/j.prostaglandins.2019.106385_bib0225","doi-asserted-by":"crossref","first-page":"103236","DOI":"10.18632\/oncotarget.21139","article-title":"Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury","volume":"8","author":"Hung","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.prostaglandins.2019.106385_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135392","article-title":"Western blotting inaccuracies with unverified antibodies: need for a western blotting minimal reporting standard (WBMRS)","volume":"10","author":"Gilda","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jnr.21827","article-title":"Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes","volume":"87","author":"Rawal","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/abbi.2000.1810","article-title":"Cress and potato soluble epoxide hydrolases: purification, biochemical characterization, and comparison to mammalian enzymes","volume":"378","author":"Morisseau","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0245","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/jnc.13933","article-title":"Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen-glucose deprivation","volume":"140","author":"Zhang","year":"2017","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0250","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainres.2006.06.041","article-title":"Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes","volume":"1111","author":"Guo","year":"2006","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0255","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jb\/mvw009","article-title":"Microglia in central nervous system repair after injury","volume":"159","author":"Jin","year":"2016","journal-title":"J. Biochem."},{"issue":"14","key":"10.1016\/j.prostaglandins.2019.106385_bib0260","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1073\/pnas.1819234116","article-title":"Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation","volume":"116","author":"Ma","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2013.06.012","article-title":"Correlated sodium and potassium imbalances within the ischemic core in experimental stroke: a 23Na MRI and histochemical imaging study","volume":"1527","author":"Yushmanov","year":"2013","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.prostaglandins.2019.106385_bib0270","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10072-017-2938-1","article-title":"Pathogenic mechanisms following ischemic stroke","volume":"38","author":"Khoshnam","year":"2017","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.prostaglandins.2019.106385_bib0275","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1073\/pnas.1315943111","article-title":"Ischemic neurons recruit natural killer cells that accelerate brain infarction","volume":"111","author":"Gan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-3639.2000.tb00247.x","article-title":"Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia","volume":"10","author":"del Zoppo","year":"2000","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0285","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1038\/s41598-018-23504-1","article-title":"Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia","volume":"8","author":"Tu","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0290","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","article-title":"Soluble epoxide hydrolase: a novel therapeutic target in stroke","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0295","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.fjc.0000189600.74157.6d","article-title":"An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats","volume":"46","author":"Dorrance","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0300","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2353\/ajpath.2009.080544","article-title":"Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection","volume":"174","author":"Simpkins","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2019.106385_bib0305","doi-asserted-by":"crossref","first-page":"H1605","DOI":"10.1152\/ajpheart.00471.2013","article-title":"Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke","volume":"305","author":"Shaik","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0310","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.freeradbiomed.2005.08.044","article-title":"Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia","volume":"40","author":"Muralikrishna","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0315","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1371\/journal.pone.0000156","article-title":"Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model","volume":"2","author":"Lee","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0320","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/JMN:14:3:197","article-title":"Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal","volume":"14","author":"Jin","year":"2000","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0325","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ijcard.2012.03.167","article-title":"A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction","volume":"167","author":"Xu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2015.02.012","article-title":"Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARgamma mediated pathways in 3T3-L1 adipocytes","volume":"406","author":"Hasan","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0335","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41598-017-18558-6","article-title":"Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0340","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0896-6273(01)00561-X","article-title":"A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF","volume":"33","author":"Tao","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2005.10.004","article-title":"Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine","volume":"1067","author":"Liu","year":"2006","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.prostaglandins.2019.106385_bib0350","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2012.98","article-title":"The immunology of acute stroke","volume":"8","author":"Chamorro","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"33","key":"10.1016\/j.prostaglandins.2019.106385_bib0355","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.2174\/138161208786848766","article-title":"Inflammation as therapeutic objective in stroke","volume":"14","author":"Jordan","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1254\/jphs.CRJ06005X","article-title":"Brain cytokines and chemokines: roles in ischemic injury and pain","volume":"100","author":"Minami","year":"2006","journal-title":"J. Pharmacol. Sci."},{"issue":"5431","key":"10.1016\/j.prostaglandins.2019.106385_bib0365","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2014.01.045","article-title":"EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells","volume":"727","author":"Jiang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0375","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.174.1.68","article-title":"Distinct calcium channels regulate responses of primary B lymphocytes to B cell receptor engagement and mechanical stimuli","volume":"174","author":"Liu","year":"2005","journal-title":"J. Immunol."},{"issue":"6947","key":"10.1016\/j.prostaglandins.2019.106385_bib0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature01807","article-title":"Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels","volume":"424","author":"Watanabe","year":"2003","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.prostaglandins.2019.106385_bib0385","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000247065.11756.19","article-title":"Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury","volume":"99","author":"Alvarez","year":"2006","journal-title":"Circ. Res."},{"issue":"6081","key":"10.1016\/j.prostaglandins.2019.106385_bib0390","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1126\/science.1216283","article-title":"Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function","volume":"336","author":"Sonkusare","year":"2012","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.prostaglandins.2019.106385_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026591","article-title":"Endogenous epoxygenases are modulators of monocyte\/macrophage activity","volume":"6","author":"Bystrom","year":"2011","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.prostaglandins.2019.106385_bib0400","doi-asserted-by":"crossref","first-page":"E3240","DOI":"10.1073\/pnas.1521453113","article-title":"CYP450-derived oxylipins mediate inflammatory resolution","volume":"113","author":"Gilroy","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"10.1016\/j.prostaglandins.2019.106385_bib0405","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139","author":"DiSabato","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0410","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0415","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","article-title":"COX-2 and neurodegeneration in Parkinson\u2019s disease","volume":"991","author":"Teismann","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0420","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-11-52","article-title":"LRRK2 and neuroinflammation: partners in crime in Parkinson\u2019s disease?","volume":"11","author":"Russo","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0425","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12035-014-8833-3","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates MPTP-induced parkinsonism","volume":"52","author":"Qin","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0435","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/jpet.106.103556","article-title":"Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels","volume":"318","author":"Olearczyk","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0440","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","article-title":"Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease","volume":"341","author":"Sherer","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"20","key":"10.1016\/j.prostaglandins.2019.106385_bib0445","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1111\/febs.12401","article-title":"Rotenone induces neuronal death by microglial phagocytosis of neurons","volume":"280","author":"Emmrich","year":"2013","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.prostaglandins.2019.106385_bib0450","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2457fje","article-title":"MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0455","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuro.2018.11.010","article-title":"Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: implications for Parkinson\u2019s disease","volume":"70","author":"Lakkappa","year":"2019","journal-title":"Neurotoxicology"},{"issue":"10","key":"10.1016\/j.prostaglandins.2019.106385_bib0460","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nn.3209","article-title":"Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson\u2019s disease","volume":"15","author":"Goldberg","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0465","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0026-895X(24)12026-3","article-title":"Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids","volume":"55","author":"Chen","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0470","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0475","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0480","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0485","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00877244","article-title":"A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion","volume":"10","author":"Mittelman","year":"1992","journal-title":"Invest. New Drugs"},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0490","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-0102(01)00309-1","article-title":"The role of TNF-alpha in amygdala kindled rats","volume":"42","author":"Shandra","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0495","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbi.2014.07.016","article-title":"Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy","volume":"43","author":"Hung","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080922","article-title":"Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures","volume":"8","author":"Inceoglu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0505","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neuropharm.2017.05.013","article-title":"11,12 -Epoxyeicosatrienoic acid (11,12 EET) reduces excitability and excitatory transmission in the hippocampus","volume":"123","author":"Mule","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0510","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3467805","article-title":"Soluble epoxide hydrolase inhibitor and 14,15-Epoxyeicosatrienoic acid-facilitated long-term potentiation through cAMP and CaMKII in the Hippocampus","volume":"2017","author":"Wu","year":"2017","journal-title":"Neural Plast."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0515","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.npp.1301252","article-title":"Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats","volume":"32","author":"Garcia-Bueno","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0520","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2005.01.002","article-title":"The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes","volume":"107","author":"Bridges","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0525","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in Major Depressive Disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0530","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0535","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/mp.2008.48","article-title":"Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment","volume":"14","author":"Bull","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.prostaglandins.2019.106385_bib0540","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0545","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bcp.2015.03.011","article-title":"Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs","volume":"95","author":"Dale","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0550","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/jnr.24080","article-title":"The effects of sEH inhibitor on depression-like behavior and neurogenesis in male mice","volume":"95","author":"Wu","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"9","key":"10.1016\/j.prostaglandins.2019.106385_bib0555","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.RES.0000018162.87285.F8","article-title":"14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries","volume":"90","author":"Gauthier","year":"2002","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2019.106385_bib0560","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","article-title":"Regulation of APP cleavage by alpha-, beta- and gamma-secretases","volume":"483","author":"Nunan","year":"2000","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0565","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-beta and tau--a toxic pas de deux in Alzheimer\u2019s disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0570","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease","volume":"136","author":"Minter","year":"2016","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0575","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","article-title":"Microglial activation in Alzheimer disease: association with APOE genotype","volume":"8","author":"Egensperger","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0580","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-3-10","article-title":"Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice","volume":"3","author":"Maezawa","year":"2006","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0585","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2013.12.031","article-title":"Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0590","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3724\/SP.J.1009.2013.00207","article-title":"Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids","volume":"11","author":"Wang","year":"2013","journal-title":"Chin. J. Nat. Med."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0595","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s11596-016-1662-z","article-title":"TPPU protects tau from H2O2-induced hyperphosphorylation in HEK293\/tau cells by regulating PI3K\/AKT\/GSK-3beta pathway","volume":"36","author":"Yao","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2017.02.008","article-title":"Glutamate affects the production of epoxyeicosanoids within the brain: the up-regulation of brain CYP2J through the MAPK-CREB signaling pathway","volume":"381","author":"Liu","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0605","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2917981","article-title":"The protective role of brain CYP2J in parkinson\u2019s disease models","volume":"2018","author":"Li","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0610","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2011.07.058","article-title":"Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain","volume":"194","author":"Sarkar","year":"2011","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.prostaglandins.2019.106385_bib0615","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/nn.2213","article-title":"Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"11","author":"Sanchez-Mejia","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.prostaglandins.2019.106385_bib0620","doi-asserted-by":"crossref","first-page":"e2935","DOI":"10.1371\/journal.pone.0002935","article-title":"Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"3","author":"Rodriguez","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0625","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.428","article-title":"14,15-epoxyeicosatrienoic acid produced by cytochrome P450s enhances neurite outgrowth of PC12 and rat hippocampal neuronal cells","volume":"6","author":"Oguro","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0630","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12929-015-0202-7","article-title":"Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex","volume":"22","author":"Wu","year":"2015","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0635","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/stem.2246","article-title":"Maternal dietary imbalance between omega-6 and omega-3 polyunsaturated fatty acids impairs neocortical development via epoxy metabolites","volume":"34","author":"Sakayori","year":"2016","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0640","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1523\/JNEUROSCI.22-02-00486.2002","article-title":"Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6","volume":"22","author":"Vallieres","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0645","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"49","key":"10.1016\/j.prostaglandins.2019.106385_bib0650","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6642","key":"10.1016\/j.prostaglandins.2019.106385_bib0655","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/41493","article-title":"A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB","volume":"388","author":"DiDonato","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0660","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","author":"Israel","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1-2","key":"10.1016\/j.prostaglandins.2019.106385_bib0665","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.09.008","article-title":"Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation","volume":"83","author":"Dimitropoulou","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0670","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10739680701456960","article-title":"Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels","volume":"15","author":"Imig","year":"2008","journal-title":"Microcirculation"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0675","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prostaglandins.2012.08.001","article-title":"Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice","volume":"104-105","author":"Chaudhary","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"37","key":"10.1016\/j.prostaglandins.2019.106385_bib0680","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1073\/pnas.1806077115","article-title":"Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132","volume":"115","author":"Lahvic","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0685","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18501","article-title":"Macrophage PPARgamma inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone","volume":"5","author":"Cheng","year":"2016","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0690","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.yjmcc.2009.02.028","article-title":"Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells","volume":"46","author":"Katragadda","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0695","doi-asserted-by":"crossref","first-page":"e885","DOI":"10.1038\/cddis.2013.418","article-title":"Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response","volume":"4","author":"Samokhvalov","year":"2013","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0700","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.prostaglandins.2019.106385_bib0705","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/hh1201.092094","article-title":"Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells","volume":"88","author":"Akao","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0710","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2017.08.003","article-title":"Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors","volume":"133","author":"Inceoglu","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0715","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mito.2010.05.014","article-title":"Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?","volume":"10","author":"Witte","year":"2010","journal-title":"Mitochondrion"},{"issue":"8","key":"10.1016\/j.prostaglandins.2019.106385_bib0720","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3181\/0903-MR-97","article-title":"Transcriptional regulation of steroidogenic genes: STARD1","volume":"234","author":"Lavoie","year":"2009","journal-title":"CYP11A1 and HSD3B. Exp Biol Med (Maywood)"},{"issue":"48","key":"10.1016\/j.prostaglandins.2019.106385_bib0725","doi-asserted-by":"crossref","first-page":"18901","DOI":"10.1073\/pnas.0809765105","article-title":"Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways","volume":"105","author":"Inceoglu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.prostaglandins.2019.106385_bib0730","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1194\/jlr.M600019-JLR200","article-title":"Identification of a novel sulfonated oxysterol, 5-cholesten-3beta,25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria","volume":"47","author":"Ren","year":"2006","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0735","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1152\/ajpendo.00552.2013","article-title":"Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation","volume":"306","author":"Ren","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0740","article-title":"Alleviation of mechanical allodynia by 14,15-Epoxyeicosatrienoic acid in a central poststroke pain model: possible role of allopregnanolone and delta-subunit-Containing gamma-aminobutyric acid a receptors","author":"Chen","year":"2018","journal-title":"J. Pain"},{"issue":"46","key":"10.1016\/j.prostaglandins.2019.106385_bib0745","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.prostaglandins.2019.106385_bib0750","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.26.8.3071-3084.2006","article-title":"Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression","volume":"26","author":"Hu","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"29","key":"10.1016\/j.prostaglandins.2019.106385_bib0755","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.1510137112","article-title":"Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain","volume":"112","author":"Inceoglu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.prostaglandins.2019.106385_bib0760","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M113.458414","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue","volume":"288","author":"Bettaieb","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0765","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000430113","article-title":"14,15-epoxyeicosatrienoic Acid suppresses cigarette smoke extract-induced apoptosis in lung epithelial cells by inhibiting endoplasmic reticulum stress","volume":"36","author":"Yu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.prostaglandins.2019.106385_bib0770","doi-asserted-by":"crossref","first-page":"H724","DOI":"10.1152\/ajpheart.00979.2007","article-title":"Multiple antiapoptotic targets of the PI3K\/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia\/anoxia","volume":"294","author":"Dhanasekaran","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"47","key":"10.1016\/j.prostaglandins.2019.106385_bib0775","doi-asserted-by":"crossref","first-page":"49420","DOI":"10.1074\/jbc.M407700200","article-title":"Critical role of endogenous Akt\/IAPs and MEK1\/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death","volume":"279","author":"Hu","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.prostaglandins.2019.106385_bib0780","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1007\/s11064-017-2297-6","article-title":"14,15-EET suppresses neuronal apoptosis in ischemia-reperfusion through the mitochondrial pathway","volume":"42","author":"Geng","year":"2017","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0785","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbamcr.2010.11.012","article-title":"Integrating stress signals at the endoplasmic reticulum: the BCL-2 protein family rheostat","volume":"1813","author":"Rodriguez","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.prostaglandins.2019.106385_bib0790","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1523\/JNEUROSCI.22-24-10690.2002","article-title":"Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson\u2019s disease","volume":"22","author":"Ryu","year":"2002","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0795","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1038\/cddis.2016.173","article-title":"Mitofusin-mediated ER stress triggers neurodegeneration in pink1\/parkin models of Parkinson\u2019s disease","volume":"7","author":"Celardo","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1-2","key":"10.1016\/j.prostaglandins.2019.106385_bib0800","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchemneu.2003.12.004","article-title":"Induction of neuronal death by ER stress in Alzheimer\u2019s disease","volume":"28","author":"Katayama","year":"2004","journal-title":"J. Chem. Neuroanat."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0805","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI61332","article-title":"Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT\/mTOR signaling","volume":"122","author":"Selvaraj","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5695","key":"10.1016\/j.prostaglandins.2019.106385_bib0810","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"issue":"1-2","key":"10.1016\/j.prostaglandins.2019.106385_bib0815","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson\u2019s disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.prostaglandins.2019.106385_bib0820","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.prostaglandins.2019.106385_bib0825","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/npp.2009.31","article-title":"Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol","volume":"34","author":"Wise","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0830","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"1-4","key":"10.1016\/j.prostaglandins.2019.106385_bib0835","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.prostaglandins.2006.05.004","article-title":"Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)","volume":"82","author":"Inceoglu","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.prostaglandins.2019.106385_bib0840","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1124\/jpet.114.216598","article-title":"Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase","volume":"351","author":"McDougle","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.prostaglandins.2019.106385_bib0845","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1111\/j.1742-4658.2008.06518.x","article-title":"Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide","volume":"275","author":"Stark","year":"2008","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.prostaglandins.2019.106385_bib0850","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/mol.108.053439","article-title":"A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist","volume":"75","author":"Snider","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"30","key":"10.1016\/j.prostaglandins.2019.106385_bib0855","doi-asserted-by":"crossref","first-page":"E6034","DOI":"10.1073\/pnas.1610325114","article-title":"Anti-inflammatory omega-3 endocannabinoid epoxides","volume":"114","author":"McDougle","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0860","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-7592-1_10","article-title":"LC-MS\/MS analysis of the epoxides and diols derived from the endocannabinoid arachidonoyl ethanolamide","volume":"1730","author":"Rand","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.prostaglandins.2019.106385_bib0865","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2015.04.001","article-title":"Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive","volume":"97","author":"Sasso","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"7-8","key":"10.1016\/j.prostaglandins.2019.106385_bib0870","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mad.2010.05.003","article-title":"Mitochondrial dysfunction and intracellular calcium dysregulation in ALS","volume":"131","author":"Kawamata","year":"2010","journal-title":"Mech. Ageing Dev."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882319301364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882319301364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:01:01Z","timestamp":1761098461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882319301364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":174,"alternative-id":["S1098882319301364"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106385","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106385"}}